BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36055411)

  • 1. DCAF1 inhibits the NF-κB pathway by targeting p65.
    Huang F; Yao W; Sun B; Fujinaga K
    Immunol Lett; 2022 Sep; 249():33-42. PubMed ID: 36055411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
    Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
    J Virol; 2017 May; 91(9):. PubMed ID: 28202763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.
    Hakata Y; Miyazawa M; Landau NR
    Virol J; 2014 Jun; 11():108. PubMed ID: 24912982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
    Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
    J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase.
    Zhou X; DeLucia M; Hao C; Hrecka K; Monnie C; Skowronski J; Ahn J
    J Biol Chem; 2017 Dec; 292(51):21117-21127. PubMed ID: 29079575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.
    Gérard FC; Yang R; Romani B; Poisson A; Belzile JP; Rougeau N; Cohen ÉA
    PLoS One; 2014; 9(2):e89195. PubMed ID: 24558487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Vpr Reprograms CLR4
    Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
    mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.
    Wen X; Casey Klockow L; Nekorchuk M; Sharifi HJ; de Noronha CM
    PLoS One; 2012; 7(1):e30939. PubMed ID: 22292079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest.
    Wei W; Guo H; Han X; Liu X; Zhou X; Zhang W; Yu XF
    Cell Microbiol; 2012 Nov; 14(11):1745-56. PubMed ID: 22776683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
    Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
    J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.
    Maudet C; Sourisce A; Dragin L; Lahouassa H; Rain JC; Bouaziz S; Ramirez BC; Margottin-Goguet F
    PLoS One; 2013; 8(10):e77320. PubMed ID: 24116224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.
    Liang Z; Liu R; Lin Y; Liang C; Tan J; Qiao W
    Virol Sin; 2015 Dec; 30(6):441-8. PubMed ID: 26676942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β.
    Liu R; Tan J; Lin Y; Jia R; Yang W; Liang C; Geng Y; Qiao W
    Virology; 2013 Apr; 439(1):47-56. PubMed ID: 23453579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
    Le Rouzic E; Morel M; Ayinde D; Belaïdouni N; Letienne J; Transy C; Margottin-Goguet F
    J Biol Chem; 2008 Aug; 283(31):21686-92. PubMed ID: 18524771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
    Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
    Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
    Cassiday PA; DePaula-Silva AB; Chumley J; Ward J; Barker E; Planelles V
    Virology; 2015 Feb; 476():19-25. PubMed ID: 25499532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7.
    Zhou X; Monnie C; DeLucia M; Ahn J
    Virol J; 2021 Mar; 18(1):48. PubMed ID: 33648539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.
    Le Rouzic E; Belaïdouni N; Estrabaud E; Morel M; Rain JC; Transy C; Margottin-Goguet F
    Cell Cycle; 2007 Jan; 6(2):182-8. PubMed ID: 17314515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.
    Kogan M; Deshmane S; Sawaya BE; Gracely EJ; Khalili K; Rappaport J
    J Cell Physiol; 2013 Apr; 228(4):781-90. PubMed ID: 23001849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.